Anders Gersel Pedersen retires from Lundbeck

Please join us in thanking Anders Gersel Pedersen for 19 years of dedication, hard work and commitment to Lundbeck and people living with diseases of the brain.

H. Lundbeck A/S (Lundbeck) announced on December 4, 2018 that Anders Gersel Pedersen, Executive Vice President and Head of Research and Development (R&D), will retire after 19 years with the company. Anders Gersel’s retirement will be effective as of 31 December 2018.

Anders Gersel Pedersen joined Lundbeck in 2000 as Vice President of International Clinical Research. Anders was later appointed Executive Vice President of Drug Development and in 2011 appointed responsible for all Research & Development activities at Lundbeck.

Read the full release about Anders Gersel Pedersen’s retirement here: https://investor.lundbeck.com/news-releases/news-release-details/lundbeck-announces-retirement-anders-gersel-pedersen-evp-and.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.